Gabelli Funds’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $977K | Hold |
17,300
| – | – | 0.01% | 905 |
|
|
2025
Q4 | $1.03M | Sell |
17,300
-12,500
| -42% | -$681K | 0.01% | 901 |
|
|
2025
Q3 | $1.61M | Buy |
29,800
+6,000
| +25% | +$343K | 0.01% | 803 |
|
|
2025
Q2 | $1.31M | Buy |
23,800
+7,000
| +42% | +$412K | 0.01% | 833 |
|
|
2025
Q1 | $1.19M | Sell |
16,800
-3,539
| -17% | -$238K | 0.01% | 752 |
|
|
2024
Q4 | $1.34M | Buy |
20,339
+7,500
| +58% | +$502K | 0.01% | 728 |
|
|
2024
Q3 | $902K | Buy |
12,839
+4,800
| +60% | +$401K | 0.01% | 801 |
|
|
2024
Q2 | $662K | Buy |
8,039
+1,114
| +16% | +$92.7K | 0.01% | 850 |
|
|
2024
Q1 | $605K | Sell |
6,925
-250
| -3% | -$22.4K | ﹤0.01% | 869 |
|
|
2023
Q4 | $692K | Sell |
7,175
-1,030
| -13% | -$91.1K | 0.01% | 851 |
|
|
2023
Q3 | $726K | Sell |
8,205
-500
| -6% | -$44.5K | 0.01% | 849 |
|
|
2023
Q2 | $755K | Sell |
8,705
-85
| -1% | -$8K | 0.01% | 850 |
|
|
2023
Q1 | $855K | Buy |
8,790
+255
| +3% | +$26.4K | 0.01% | 831 |
|
|
2022
Q4 | $883K | Sell |
8,535
-10,085
| -54% | -$947K | 0.01% | 822 |
|
|
2022
Q3 | $1.58M | Buy |
18,620
+250
| +1% | +$22.3K | 0.01% | 706 |
|
|
2022
Q2 | $1.52M | Buy |
18,370
+750
| +4% | +$59.7K | 0.01% | 738 |
|
|
2022
Q1 | $1.36M | Sell |
17,620
-2,620
| -13% | -$219K | 0.01% | 810 |
|
|
2021
Q4 | $1.79M | Sell |
20,240
-13,740
| -40% | -$1.13M | 0.01% | 758 |
|
|
2021
Q3 | $2.63M | Buy |
33,980
+60
| +0.2% | +$4.73K | 0.02% | 671 |
|
|
2021
Q2 | $2.83M | Sell |
33,920
-750
| -2% | -$59.5K | 0.02% | 675 |
|
|
2021
Q1 | $2.62M | Buy |
34,670
+29,170
| +530% | +$2.38M | 0.02% | 671 |
|
|
2020
Q4 | $482K | Buy |
5,500
+1,725
| +46% | +$137K | ﹤0.01% | 1007 |
|
|
2020
Q3 | $287K | Buy |
3,775
+1,825
| +94% | +$185K | ﹤0.01% | 990 |
|
|
2020
Q2 | $241K | Buy |
+1,950
| New | +$194K | ﹤0.01% | 970 |
|
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$309K | – | 1121 |
|
|
2017
Q2 | $309K | Sell |
3,400
-6,300
| -65% | -$573K | ﹤0.01% | 1061 |
|
|
2017
Q1 | $851K | Buy |
+9,700
| New | +$863K | 0.01% | 928 |
|
|
2016
Q4 | – | Sell |
-30,000
| Closed | -$2.78M | – | 1145 |
|
|
2016
Q3 | $2.78M | Sell |
30,000
-75,786
| -72% | -$7.14M | 0.02% | 708 |
|
|
2016
Q2 | $8.23M | Buy |
+105,786
| New | +$8.99M | 0.05% | 431 |
|
Other funds holding BMRN
VCM
VPM
